BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simunovic M, Supe-Domic D, Karin Z, Degoricija M, Paradzik M, Bozic J, Unic I, Skrabic V. Serum catestatin concentrations are decreased in obese children and adolescents. Pediatr Diabetes. 2019;20:549-555. [PMID: 30714297 DOI: 10.1111/pedi.12825] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kumric M, Vrdoljak J, Dujic G, Supe-domic D, Ticinovic Kurir T, Dujic Z, Bozic J. Serum Catestatin Levels Correlate with Ambulatory Blood Pressure and Indices of Arterial Stiffness in Patients with Primary Hypertension. Biomolecules 2022;12:1204. [DOI: 10.3390/biom12091204] [Reference Citation Analysis]
2 Kljakovic-gaspic T, Tokic D, Martinovic D, Kumric M, Supe-domic D, Stojanovic Stipic S, Delic N, Vrdoljak J, Vilovic M, Ticinovic Kurir T, Bozic J. Prognostic Value of Catestatin in Severe COVID-19: An ICU-Based Study. JCM 2022;11:4496. [DOI: 10.3390/jcm11154496] [Reference Citation Analysis]
3 Zalewska E, Kmieć P, Sworczak K. Role of Catestatin in the Cardiovascular System and Metabolic Disorders. Front Cardiovasc Med 2022;9:909480. [DOI: 10.3389/fcvm.2022.909480] [Reference Citation Analysis]
4 Raza GS, Herzig KH. Hepatic glucose production and storage as a potential strategy for type 2 diabetes treatment - The effect of catestatin - "just another new kid in town?". Acta Physiol (Oxf) 2022;235:e13808. [PMID: 35224867 DOI: 10.1111/apha.13808] [Reference Citation Analysis]
5 Bozic J, Kumric M, Ticinovic Kurir T, Urlic H, Martinovic D, Vilovic M, Tomasovic Mrcela N, Borovac JA. Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective. Biomedicines 2021;9:1757. [PMID: 34944578 DOI: 10.3390/biomedicines9121757] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Herold Z, Doleschall M, Somogyi A. Role and function of granin proteins in diabetes mellitus. World J Diabetes 2021;12:1081-92. [PMID: 34326956 DOI: 10.4239/wjd.v12.i7.1081] [Reference Citation Analysis]
7 Watanabe T. The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease. Int J Mol Sci 2021;22:6118. [PMID: 34204153 DOI: 10.3390/ijms22116118] [Reference Citation Analysis]
8 Bourebaba Y, Mularczyk M, Marycz K, Bourebaba L. Catestatin peptide of chromogranin A as a potential new target for several risk factors management in the course of metabolic syndrome. Biomed Pharmacother 2021;134:111113. [PMID: 33341043 DOI: 10.1016/j.biopha.2020.111113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zivkovic PM, Matetic A, Tadin Hadjina I, Rusic D, Vilovic M, Supe-Domic D, Borovac JA, Mudnic I, Tonkic A, Bozic J. Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease. J Clin Med. 2020;9. [PMID: 32110996 DOI: 10.3390/jcm9030628] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
10 Borovac JA, Glavas D, Susilovic Grabovac Z, Supe Domic D, D'Amario D, Bozic J. Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study. J Clin Med. 2019;8. [PMID: 31366074 DOI: 10.3390/jcm8081132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]